Telix Pharmaceuticals Limited Tech Stack
Public radiopharmaceutical company advancing oncology theranostics toward commercial launch
Telix is a clinical-stage biopharmaceutical company developing radiopharmaceuticals for oncology and rare diseases, now in active transition from R&D to commercial operations. The hiring velocity and project focus—scaling manufacturing, rolling out prostate cancer imaging globally, and building commercial distribution—signal an organization pivoting toward product launch. Stack reveals a GxP-compliant operational layer (SAP, Veeva, SDS-PAGE) layered beneath standard BI/finance tools, consistent with a company moving from pure research into regulated manufacturing and sales execution.
Tech Stack 14 technologies
What Telix Pharmaceuticals Limited Is Building
◆Challenges
- Risk mitigation
- Advancing late clinical-stage portfolio
- International roll-out of imaging agent
- Ensuring regulatory compliance across global agencies
- Accelerating commercialization
- Contractual and license obligations
- R&d project cost management
- Identifying new cancer targets
- Late clinical-stage product development
- Transition to commercial-stage manufacturing
▲Active Projects
- Advancing late clinical-stage product portfolio
- International roll-out of prostate cancer imaging agent
- Late clinical-stage product development
- Scale-up manufacturing procedures for commercial supply
- Commercial distribution strategy implementation
- Group-wide share psar administration
- Fap imaging asset development
- Financial performance reporting for r&d projects
- Development of ich aligned cmc/technical portions of global regulatory submissions
- Late clinical-stage oncology product advancement
Hiring Activity
Department
Seniority
Notable leadership hires: Clinical Lead, Biologics Director, Employee Equity Lead, Finance Director, Strategic Account Director
